Biotech

Two injectable medications with a tape measure wrapped around them
Biotech

Gubra reveals early data for once-weekly obesity asset

Gubra’s once-weekly obesity candidate was tied to 3% weight loss during a six-week phase 1 trial, with most adverse events "mild" and "transient."
Gabrielle Masson Nov 13, 2024 5:56pm
mechanical gears shifting

Adaptimmune's cell therapy hits key goal in pivotal sarcoma test

Nov 13, 2024 2:57pm
Vaccinating Against Cancer Cells and Reprogramming the Tumor Microenvironment That Protects Them

Reprogramming the Tumor Microenvironment to Fight Cancer

Nov 11, 2024 8:00am
invest benjamin franklin dollars bills

Fierce Biotech Fundraising Tracker: TRexBio, Metsera & more

Nov 13, 2024 11:00am
Hybrid FSPFSO Solutions Keep Biotech Trials on Time and on Budget

Hybrid FSP/FSO Solutions Keep Biotech Trials on Time and on Budget

Nov 1, 2024 8:00am
two arrows combining in merger

Entero and ADC-like biotech Journey pen reverse merger

Nov 13, 2024 10:40am